A tissue-engineered stent for cell-based vascular gene transfer.

[1]  R. Levy,et al.  Gene delivery from a DNA controlled-release stent in porcine coronary arteries , 2000, Nature Biotechnology.

[2]  J. Leiden.  Human gene therapy: the good, the bad, and the ugly. , 2000, Circulation research.

[3]  Y G Meng,et al.  Green fluorescent protein as a second selectable marker for selection of high producing clones from transfected CHO cells. , 2000, Gene.

[4]  Myung Ho Jeong,et al.  Preventive effects of the heparin‐coated stent on restenosis in the porcine model , 1999, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[5]  R. Simari,et al.  Expression of tissue factor pathway inhibitor in vascular smooth muscle cells and its regulation by growth factors. , 1998, Circulation research.

[6]  J. Rumberger,et al.  Angiographic correlates of "spotty" coronary artery calcium detected by electron-beam computed tomography in patients with normal or near-normal coronary angiograms. , 1998, The American journal of cardiology.

[7]  R. Schwartz,et al.  Experimental hypercholesterolemia induces ultrastructural changes in the internal elastic lamina of porcine coronary arteries. , 1998, Atherosclerosis.

[8]  J. Feijen,et al.  Small-diameter vascular graft prostheses: current status. , 1998, Archives of physiology and biochemistry.

[9]  J. Moses,et al.  Efficacy of coronary stenting versus balloon angioplasty in small coronary arteries. Stent Restenosis Study (STRESS) Investigators. , 1998, Journal of the American College of Cardiology.

[10]  E J Topol,et al.  Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model. , 1997, Journal of the American College of Cardiology.

[11]  J. Marshall,et al.  A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  E. Topol,et al.  Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. , 1996, Circulation.

[13]  K. Robinson,et al.  Comparison of the thrombogenicity of stainless steel and tantalum coronary stents. , 1995, American heart journal.

[14]  W Rutsch,et al.  A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. , 1994, The New England journal of medicine.

[15]  R. Virmani,et al.  Genetically engineered endothelial cells remain adherent and viable after stent deployment and exposure to flow in vitro. , 1992, Circulation research.

[16]  D. Dichek,et al.  Enhancement of the fibrinolytic activity of sheep endothelial cells by retroviral vector-mediated gene transfer. , 1991, Blood.

[17]  D. Dichek,et al.  Seeding of intravascular stents with genetically engineered endothelial cells. , 1989, Circulation.

[18]  E. Nabel,et al.  Recombinant gene expression in vivo within endothelial cells of the arterial wall. , 1989, Science.

[19]  P. Libby,et al.  Implantation of vascular grafts lined with genetically modified endothelial cells. , 1989, Science.

[20]  F Joffre,et al.  Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. , 1987, The New England journal of medicine.

[21]  J. Campbell,et al.  Smooth muscle phenotypic changes in arterial wall homeostasis: implications for the pathogenesis of atherosclerosis. , 1985, Experimental and molecular pathology.

[22]  T. Clackson,et al.  Regulated gene expression systems , 2000, Gene Therapy.